Reed Jobs' venture firm, Yosemite, has expanded significantly since its inception, now employing 17 people and integrating AI into its biotech strategy. The firm is capitalizing on a unique market opportunity created by multiple blockbuster drugs nearing the end of their patent protection windows simultaneously.
Background
Biotech startups often leverage AI to accelerate drug discovery and development processes. Patent cliffs for major pharmaceuticals create significant opportunities for generic competition and innovative therapies.
- Source
- TechCrunch
- Published
- Jul 12, 2026 at 08:16 AM
- Score
- 5.0 / 10